Turning Point Therapeutics' GAAP loss for 6M 2021 was $91.777 million, down 0.5% from $92.211 million in the prior year. Revenue was $30.369 million. The company did not generate revenue a year earlier.
Turning Point Therapeutics' GAAP loss for 6M 2021 was $91.777 million, down 0.5% from $92.211 million in the prior year. Revenue was $30.369 million. The company did not generate revenue a year earlier. 
ir.tptherapeutics.com
English (US) 